Sign up to save your podcasts
Or
Share Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic
Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)?
Credit available for this activity expires: 6/20/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726
View all episodes
By Medscape Podcasts
4
77 ratings
Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)?
Credit available for this activity expires: 6/20/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726
More shows like Keeping Current
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
322 Listeners
JAMA Clinical Reviews
498 Listeners
Diabetes Core Update
102 Listeners
This Week in Cardiology
881 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
88 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
26 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
The Curious Clinicians
370 Listeners